Vicarious Surgical Enhances CEO and CFO Severance Protections

Vicarious Surgical ( (RBOT) ) has provided an announcement.

On February 2, 2026, Vicarious Surgical Inc. amended the employment agreement of Chief Executive Officer Stephen From to enhance his severance protections, including up to two years’ worth of salary and target bonus components, extended COBRA coverage, and full vesting of time-based equity awards if he is terminated without cause or resigns for good reason in connection with a change in control, subject to customary release and restrictive covenants. On February 1, 2026, the company also entered into a similar severance and change-in-control agreement with Chief Financial Officer Sarah Romano, granting her up to one year of salary and target bonus components, extended COBRA coverage, and full vesting of time-based equity awards under change-in-control termination scenarios, moves that underscore the company’s effort to secure and retain key leadership through potentially transformative corporate events.

The most recent analyst rating on (RBOT) stock is a Hold with a $2.00 price target. To see the full list of analyst forecasts on Vicarious Surgical stock, see the RBOT Stock Forecast page.

Spark’s Take on RBOT Stock

According to Spark, TipRanks’ AI Analyst, RBOT is a Neutral.

The score is held down primarily by very weak financial performance (no revenue, large ongoing losses, heavy cash burn, and sharply reduced equity). Technicals also remain unfavorable with a clear longer-term downtrend and negative MACD. Offsetting factors include cost-cutting progress and improved cash-burn guidance plus financing actions, but these are not yet enough to outweigh the current funding and execution risk.

To see Spark’s full report on RBOT stock, click here.

More about Vicarious Surgical

Average Trading Volume: 145,081

Technical Sentiment Signal: Sell

Current Market Cap: $15.66M

Learn more about RBOT stock on TipRanks’ Stock Analysis page.